JP2023546503A5 - - Google Patents
Info
- Publication number
- JP2023546503A5 JP2023546503A5 JP2023525041A JP2023525041A JP2023546503A5 JP 2023546503 A5 JP2023546503 A5 JP 2023546503A5 JP 2023525041 A JP2023525041 A JP 2023525041A JP 2023525041 A JP2023525041 A JP 2023525041A JP 2023546503 A5 JP2023546503 A5 JP 2023546503A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- pharmaceutical composition
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105810P | 2020-10-26 | 2020-10-26 | |
| US63/105,810 | 2020-10-26 | ||
| US202163250114P | 2021-09-29 | 2021-09-29 | |
| US63/250,114 | 2021-09-29 | ||
| PCT/EP2021/079566 WO2022090169A1 (en) | 2020-10-26 | 2021-10-25 | Method of safe administration of anti-tau antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546503A JP2023546503A (ja) | 2023-11-02 |
| JP2023546503A5 true JP2023546503A5 (https=) | 2024-09-20 |
Family
ID=78483271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525041A Withdrawn JP2023546503A (ja) | 2020-10-26 | 2021-10-25 | 抗タウ抗体の安全な投与方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220127346A1 (https=) |
| EP (1) | EP4232472A1 (https=) |
| JP (1) | JP2023546503A (https=) |
| KR (1) | KR20230097110A (https=) |
| AU (1) | AU2021370222A1 (https=) |
| CA (1) | CA3199808A1 (https=) |
| IL (1) | IL302383A (https=) |
| MX (1) | MX2023004832A (https=) |
| TW (1) | TW202231661A (https=) |
| WO (1) | WO2022090169A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3093200A1 (en) | 2018-03-05 | 2019-09-12 | Janssen Pharmaceutica Nv | Anti-phf-tau antibodies and uses thereof |
| US20230235034A1 (en) * | 2020-05-26 | 2023-07-27 | The Trustees Of The University Of Pennsylvania | Monoclonal antibodies against pathological tau, and methods using same |
| CA3199806A1 (en) * | 2020-10-26 | 2022-05-05 | Janssen Pharmaceutica Nv | Methods of reducing tau in human subjects |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| TWI771389B (zh) * | 2017-03-16 | 2022-07-21 | 美商健生生物科技公司 | 抗phf-tau抗體及其用途 |
| US10646569B2 (en) * | 2017-05-16 | 2020-05-12 | Bhami's Research Laboratory, Pvt. Ltd. | High concentration protein formulations with reduced viscosity |
-
2021
- 2021-10-25 WO PCT/EP2021/079566 patent/WO2022090169A1/en not_active Ceased
- 2021-10-25 IL IL302383A patent/IL302383A/en unknown
- 2021-10-25 AU AU2021370222A patent/AU2021370222A1/en active Pending
- 2021-10-25 TW TW110139446A patent/TW202231661A/zh unknown
- 2021-10-25 EP EP21801461.1A patent/EP4232472A1/en active Pending
- 2021-10-25 KR KR1020237017905A patent/KR20230097110A/ko active Pending
- 2021-10-25 CA CA3199808A patent/CA3199808A1/en active Pending
- 2021-10-25 MX MX2023004832A patent/MX2023004832A/es unknown
- 2021-10-25 JP JP2023525041A patent/JP2023546503A/ja not_active Withdrawn
- 2021-10-25 US US17/509,910 patent/US20220127346A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517236A5 (https=) | ||
| TWI601537B (zh) | 抗－ｃｄ１９類美登醇（ｍａｙｔａｎｓｉｎｏｉｄ）免疫結合物抗體於治療ｂ－細胞惡性症狀之用途 | |
| JP2023546503A5 (https=) | ||
| US11591406B2 (en) | Treatment for multiple myeloma (MM) | |
| JP2024531151A5 (https=) | ||
| JP2016528247A5 (https=) | ||
| JP2003531129A5 (https=) | ||
| JP2023551559A5 (https=) | ||
| JP2019532970A5 (https=) | ||
| JP2024540226A5 (https=) | ||
| JP2023517611A5 (https=) | ||
| JP2022512704A5 (https=) | ||
| JP2023520771A5 (https=) | ||
| JP2023510199A5 (https=) | ||
| KR20240117655A (ko) | 항-cd19 항체 및 베네토클락스 조합 치료에 대한 치료 패러다임 | |
| TWI870592B (zh) | 使用免疫檢查點抑制劑抗體治療癌症之方法和組合 | |
| US20220127346A1 (en) | Methods of Safe Administration of Anti-Tau Antibody | |
| JP2023542879A5 (https=) | ||
| JP2023545084A5 (https=) | ||
| JP2023546504A5 (https=) | ||
| JP2023510854A5 (https=) | ||
| JP2024521105A5 (https=) | ||
| JP2022514561A5 (https=) | ||
| JP2020505350A5 (https=) | ||
| JP2025500483A5 (https=) |